Prot #AG881-C-004: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
- Kumthekar, Priya U (PD/PI)
Project: Research project
Project: Research project